Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.


PURPOSE Lynch syndrome is associated with inherited germline mutations in mismatch repair (MMR) genes. Genetic testing in high-risk individuals may yield indeterminate results if no mutation is found or if a mutation of unclear pathogenic significance is observed. There are limited data regarding how well patients with Lynch syndrome understand the clinical implications of genetic test results. This study examines colorectal cancer (CRC) risk perception in individuals tested for MMR mutations and identifies the factors associated with an appropriate interpretation of their cancer risk. PATIENTS AND METHODS A total of 159 individuals who met the Revised Bethesda Guidelines and had previously undergone genetic testing completed a questionnaire eliciting demographic data, cancer history, genetic test results, and an estimate of their CRC risk. Associations between clinical factors, genetic test results, and CRC risk perception were explored using multivariable analyses. RESULTS Of the 100 individuals with a pathogenic mutation (true positive), 90 (90%) correctly estimated their CRC risk as "high" or "very high" compared with other individuals their age. However, only 23 (62%) of 37 individuals with an indeterminate genetic test result correctly estimated their risk. Individuals with a history of Lynch syndrome-associated cancer (odds ratio [OR], 0.1; 95% CI, 0.1 to 0.6) or indeterminate genetic test results (OR, 0.2; 95% CI, 0.1 to 0.6) were significantly less likely to estimate their CRC risk as increased. CONCLUSION Patients at risk for Lynch syndrome with an indeterminate genetic test result may be falsely reassured. It is important that health care providers continue to discuss the implications of uninformative results on lifetime cancer risk.

DOI: 10.1200/JCO.2008.18.6940

Cite this paper

@article{Grover2009ColorectalCR, title={Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome.}, author={Shilpa Grover and Elena M. Stoffel and Rowena Cabigon Mercado and Beth M. Ford and Wendy K Kohlman and Kristen Mahoney Shannon and Peggy G. Conrad and Amie M. Blanco and Jonathan P. Terdiman and Stephen B. Gruber and Daniel C. Chung and Sapna Syngal}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2009}, volume={27 24}, pages={3981-6} }